Valdecoxib is used in osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, gout, arthralgia, myalgia, pain during menstruation and post operative pain.
How it works
Valdecoxib blocks the release of certain chemical messengers that are responsible for pain and inflammation (redness and swelling).
Common side effects
Abdominal pain, Palpitations, Nausea, Vomiting, Headache, Heartburn, Gastritis, Dizziness, Flatulence, Edema, Increased blood pressure, Dyspepsia, Constipation, Diarrhoea
- ₹9Glenmark Pharmaceuticals Ltd1 variant(s)
- ₹29Torrent Pharmaceuticals Ltd1 variant(s)
- ₹22Blue Cross Laboratories Ltd1 variant(s)
- ₹50Glenmark Pharmaceuticals Ltd1 variant(s)
- ₹19 to ₹30Geno Pharmaceuticals Ltd2 variant(s)
- ₹19 to ₹65Sun Pharmaceutical Industries Ltd2 variant(s)
- ₹19 to ₹37Cipla Ltd2 variant(s)
- ₹19 to ₹51Cadila Pharmaceuticals Ltd3 variant(s)
- ₹20 to ₹35Orchid Chemicals & Pharmaceuticals Ltd2 variant(s)
- ₹29Intas Pharmaceuticals Ltd1 variant(s)
- Before you take valdecoxib, inform your doctor if you suffer from liver and or kidney problems.
- Do not take valdecoxib if you have experienced asthma, hives or any allergic reaction after taking a sulfabased medication.
- Stop taking valdecoxib and contact your doctor immediately if you develop a skin rash, hives, itching, difficulty breathing, swelling of the lips, tongue or face, or other symptoms of an allergic reaction.
- Caution should be exercised while using valdecoxib as an increased risk of cardiovascular events (including heart attack and stroke) have been reported with its use.
- Overdose of valdecoxib may cause dizziness; it is advisable to avoid driving or operating heavy machinery under such circumstances.
- Tell your doctor if you are or planning to become pregnant or are breastfeeding.
Frequently asked questions
Q. What is valdecoxib tablet and what are they used for?
Valdecoxib tablets are pain killer tablets used in treating the pain and inflammation caused by arthritis and for painful menstruation
Q. Why is valdecoxib banned?
Valdecoxib was banned due to safety concerns of an increased risk of cardiovascular events and serious and potentially life-threatening skin reactions.